ZA794156B - Thio-substituted diazacycloalkenes,processes for their preparation and pharmaceutical preparations - Google Patents

Thio-substituted diazacycloalkenes,processes for their preparation and pharmaceutical preparations

Info

Publication number
ZA794156B
ZA794156B ZA00794156A ZA794156A ZA794156B ZA 794156 B ZA794156 B ZA 794156B ZA 00794156 A ZA00794156 A ZA 00794156A ZA 794156 A ZA794156 A ZA 794156A ZA 794156 B ZA794156 B ZA 794156B
Authority
ZA
South Africa
Prior art keywords
diazacycloalkenes
thio
substituted
processes
preparation
Prior art date
Application number
ZA00794156A
Other languages
English (en)
Inventor
P Ferrini
R Goeschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ZA794156B publication Critical patent/ZA794156B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Luminescent Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
ZA00794156A 1978-08-10 1979-08-09 Thio-substituted diazacycloalkenes,processes for their preparation and pharmaceutical preparations ZA794156B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH852678 1978-08-10

Publications (1)

Publication Number Publication Date
ZA794156B true ZA794156B (en) 1980-08-27

Family

ID=4341567

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00794156A ZA794156B (en) 1978-08-10 1979-08-09 Thio-substituted diazacycloalkenes,processes for their preparation and pharmaceutical preparations

Country Status (15)

Country Link
US (1) US4308277A (xx)
EP (1) EP0008073A1 (xx)
JP (1) JPS5547660A (xx)
AU (1) AU4973979A (xx)
CA (1) CA1130288A (xx)
DD (1) DD145269A5 (xx)
DK (1) DK333279A (xx)
ES (1) ES483247A1 (xx)
FI (1) FI792449A (xx)
GR (1) GR72493B (xx)
IL (1) IL58007A0 (xx)
NO (1) NO792597L (xx)
PL (2) PL224554A1 (xx)
PT (1) PT70046A (xx)
ZA (1) ZA794156B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2963572D1 (en) * 1978-04-11 1982-10-21 Ciba Geigy Ag Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions
DE3337181A1 (de) * 1983-10-13 1985-04-25 Hoechst Ag, 6230 Frankfurt Neue 4-substituierte-(delta) 2-imidazolinyl-thioether und verfahren zu ihrer herstellung
DE3337180A1 (de) * 1983-10-13 1985-04-25 Hoechst Ag, 6230 Frankfurt Neue 5-substituierte -(delta)2-imidazolinyl-thioether und verfahren zu iherer herstellung
US4686231A (en) * 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
US4780470A (en) * 1986-08-19 1988-10-25 Smithkline Beckman Corporation Inhibition of interleukin-1 by monocytes and/or macrophages
GB0324498D0 (en) * 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981739A (en) * 1958-01-27 1961-04-25 Diamond Alkali Co Certain alpha-haloaldehyde addition products of ethylenethioureas and process
SE428686B (sv) * 1975-08-11 1983-07-18 Du Pont Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler
US4190666A (en) * 1975-08-11 1980-02-26 E. I. Du Pont De Nemours And Company Anti-inflammatory 4,5-diarly-2-(substituted-thio)imidazoles and their corresponding sulfoxides and sulfones
US4182769A (en) * 1977-02-09 1980-01-08 E. I. Du Pont De Nemours And Company Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfones
ZA78768B (en) * 1977-02-09 1979-01-31 Du Pont Anti-inflammatory imidazoles and their corresponding sulfoxides and sulfones

Also Published As

Publication number Publication date
CA1130288A (en) 1982-08-24
NO792597L (no) 1980-02-12
IL58007A0 (en) 1979-12-30
PL217683A1 (xx) 1980-11-03
JPS5547660A (en) 1980-04-04
ES483247A1 (es) 1980-04-16
AU4973979A (en) 1980-02-14
US4308277A (en) 1981-12-29
DD145269A5 (de) 1980-12-03
FI792449A (fi) 1980-02-11
GR72493B (xx) 1983-11-15
PL224554A1 (xx) 1982-02-01
DK333279A (da) 1980-02-11
EP0008073A1 (de) 1980-02-20
PT70046A (en) 1979-09-01

Similar Documents

Publication Publication Date Title
ZA793542B (en) Pharmaceutical preparations
ZA803567B (en) Pharmaceutical preparations
DE3067252D1 (en) Cyclopeptides and pharmaceutical preparations thereof, process for their preparation and their use
CY1250A (en) N-heterocyclyl-4-piperdinamines,methods for their preparation and pharmaceutical compositions comprising them
ZA795039B (en) Pharmaceutical preparations
PH19245A (en) Pharmaceutical preparations
DE3262516D1 (en) Omega-cyano-1, omega-diphenyl azalcane derivatives, their preparation and pharmaceutical preparations containing them
ZA796549B (en) New pharmaceutical preparations
IL57901A0 (en) Indanyl derivatives,process for their preparation and pharmaceutical preparations containing them
DE2964249D1 (en) Isoquinoline derivatives, process for their preparation and pharmaceutical preparations containing them
GB2038812B (en) 1,2,4,5-tetra - alkyl - 4 - phenylpiperidines and pharmaceutical preparations thereof
IL57599A0 (en) Indolealkylamines,pharmaceutical formulations containing these and processes for their preparation
IL57802A (en) Thio-substituted benzoylpropionyl-l-prolines,their preparation and pharmaceutical compositions comprising them
DE2961268D1 (en) Bicyclo-compounds, processes for their preparation and their application
ZA793131B (en) Indolealkylamines,pharmaceutical formulations containing these,and processes for their preparation
DE2960675D1 (en) Isoquinolines, process for their preparation, and pharmaceutical preparations containing them
ZA794156B (en) Thio-substituted diazacycloalkenes,processes for their preparation and pharmaceutical preparations
ZA818968B (en) Thiaoline derivatives,processes for their preparation,their use and pharmaceutical preparations based on these compounds
ZA793336B (en) Novel phenylpiperidine derivatives,processes for their preparation,pharmaceutical preparations containing these derivatives and their use
DE2961213D1 (en) Thieno and furopyridone derivatives, process for their preparation and medicinal preparations containing them
DE3169963D1 (en) Anthracyclinglycosides, their preparation and pharmaceutical preparations
DE2962711D1 (en) Water-insoluble disazodyestuffs, their preparation and application
ZA79627B (en) Modified azulmic acids,processes for their preparation and their use
PH17121A (en) Pharmaceutical preparations
MY8500681A (en) Pharmaceutical preparations